Abstract
In PNAS, Hsu et al. (1) observed an early transient increase (here, termed a blip) in hepatitis C virus (HCV) viral load in 92 out of 145 Taiwanese patients with chronic hepatitis C treated with pegylated IFN-α (IFN) and ribavirin and found that these blips were significantly associated with the outcome of therapy [i.e., sustained virologic response (SVR)]. Further, they sought to explain the origin and time of these blips using a version of a well-studied mathematical model of HCV infection and treatment (2) in a nonstandard way. Although these blips are interesting, several concerns need to be raised before further interpretation of the findings of Hsu et al. (1) is made.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have